Greg Zante - Net Worth and Insider Trading
Greg Zante Net Worth
The estimated net worth of Greg Zante is at least $6 Million dollars as of 2024-12-28. Greg Zante is the CFO of Viking Therapeutics Inc and owns about 149,366 shares of Viking Therapeutics Inc (VKTX) stock worth over $6 Million. Greg Zante is also the Vice President, Fin. & Admin. of Sangamo Therapeutics Inc and owns about 0 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $0. Details can be seen in Greg Zante's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Greg Zante has not made any transactions after 2024-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Greg Zante
Greg Zante Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Greg Zante owns 2 companies in total, including Sangamo Therapeutics Inc (SGMO) , and Viking Therapeutics Inc (VKTX) .
Click here to see the complete history of Greg Zante’s form 4 insider trades.
Insider Ownership Summary of Greg Zante
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2008-02-14 | Sr Dir. & Finance and Admin. |
| VKTX | Viking Therapeutics Inc | 2024-10-28 | Chief Financial Officer |
Greg Zante Latest Holdings Summary
Greg Zante currently owns a total of 2 stocks. Among these stocks, Greg Zante owns 149,366 shares of Viking Therapeutics Inc (VKTX) as of October 28, 2024, with a value of $6 Million and a weighting of 100%. Greg Zante also owns 0 shares of Sangamo Therapeutics Inc (SGMO) as of February 14, 2008, with a value of $0 and a weighting of 0%.
Latest Holdings of Greg Zante
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VKTX | Viking Therapeutics Inc | 2024-10-28 | 149,366 | 41.16 | 6,147,905 |
| SGMO | Sangamo Therapeutics Inc | 2008-02-14 | 0 | 2.56 | 0 |
Holding Weightings of Greg Zante
Greg Zante Form 4 Trading Tracker
According to the SEC Form 4 filings, Greg Zante has made a total of 6 transactions in Viking Therapeutics Inc (VKTX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Viking Therapeutics Inc is the sale of 131,687 shares on October 28, 2024, which brought Greg Zante around $10 Million.
According to the SEC Form 4 filings, Greg Zante has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 5,000 shares on February 14, 2008, which brought Greg Zante around $60,100.
Insider Trading History of Greg Zante
- 1
Greg Zante Trading Performance
Greg Zante Ownership Network
Greg Zante Owned Company Details
What does Sangamo Therapeutics Inc do?
Who are the key executives at Sangamo Therapeutics Inc?
Greg Zante is the Sr Dir. & Finance and Admin. of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .
Sangamo Therapeutics Inc (SGMO) Insider Trades Summary
Over the past 18 months, Greg Zante made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.
Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sangamo Therapeutics Inc Insider Transactions
Greg Zante Mailing Address
Above is the net worth, insider trading, and ownership report for Greg Zante. You might contact Greg Zante via mailing address: C/o Sangamo Biosciences, Inc Ste-a-100, Point Richmond Tech, 501 Canal Blvd,, Richmond Ca 94804.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
